Clinical Trials Logo

Clinical Trial Summary

Obstructive sleep apnea is a common disorder linked to serious long-term adverse health consequences; such as hypertension, metabolic dysfunction, cardiovascular disease. Retinal vascular occlusion is related to many systemic illnesses especially hypertension. Obstructive sleep apnea is also related to vascular endothelial dysfunction and vascular endothelial growth factor elevation which causes vision threatening complications of retinal vascular occlusion. Therefore the relationship between obstructive sleep apnea and retinal vascular occlusion should be studied.


Clinical Trial Description

n/a


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT01291862
Study type Interventional
Source Yonsei University
Contact
Status Recruiting
Phase N/A
Start date June 2010
Completion date June 2012

See also
  Status Clinical Trial Phase
Recruiting NCT01939119 - Body-fluid Balance and Drinking Habits in Patients With Retinal Vascular Occlusion N/A
Completed NCT05657158 - Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular Occlusion